https://keshavmed.com/news/expanded-tb-screening-in-hiv-wards-fails-to-speed-treatment-clinical-trial-shows-medical-xpress-fr/ 2026-07-21T01:28:33+00:00 https://keshavmed.com/news/expanded-tb-screening-in-hiv-wards-fails-to-speed-treatment-clinical-trial-shows-medical-xpress-de/ 2026-07-21T01:28:33+00:00 https://keshavmed.com/news/expanded-tb-screening-in-hiv-wards-fails-to-speed-treatment-clinical-trial-shows-medical-xpress/ 2026-07-21T01:28:32+00:00 https://keshavmed.com/news/expanded-tb-screening-in-hiv-wards-fails-to-speed-treatment-clinical-trial-shows-medical-xpress-zh-tw/ 2026-07-21T01:28:32+00:00 https://keshavmed.com/news/small-study-shows-one-time-cell-therapy-can-control-hiv-infection-reuters-vi/ 2026-07-21T01:28:21+00:00 https://keshavmed.com/news/small-study-shows-one-time-cell-therapy-can-control-hiv-infection-reuters-ms/ 2026-07-21T01:28:21+00:00 https://keshavmed.com/news/small-study-shows-one-time-cell-therapy-can-control-hiv-infection-reuters-id/ 2026-07-21T01:28:20+00:00 https://keshavmed.com/news/small-study-shows-one-time-cell-therapy-can-control-hiv-infection-reuters-th/ 2026-07-21T01:28:20+00:00 https://keshavmed.com/news/small-study-shows-one-time-cell-therapy-can-control-hiv-infection-reuters-ru/ 2026-07-21T01:28:19+00:00 https://keshavmed.com/news/small-study-shows-one-time-cell-therapy-can-control-hiv-infection-reuters-es/ 2026-07-21T01:28:18+00:00 https://keshavmed.com/news/small-study-shows-one-time-cell-therapy-can-control-hiv-infection-reuters-ar/ 2026-07-21T01:28:18+00:00 https://keshavmed.com/news/small-study-shows-one-time-cell-therapy-can-control-hiv-infection-reuters-pt/ 2026-07-21T01:28:17+00:00 https://keshavmed.com/news/small-study-shows-one-time-cell-therapy-can-control-hiv-infection-reuters-ja/ 2026-07-21T01:28:17+00:00 https://keshavmed.com/news/small-study-shows-one-time-cell-therapy-can-control-hiv-infection-reuters-fr/ 2026-07-21T01:28:16+00:00 https://keshavmed.com/news/small-study-shows-one-time-cell-therapy-can-control-hiv-infection-reuters-de/ 2026-07-21T01:28:16+00:00 https://keshavmed.com/news/small-study-shows-one-time-cell-therapy-can-control-hiv-infection-reuters-zh-tw/ 2026-07-21T01:28:15+00:00 https://keshavmed.com/news/small-study-shows-one-time-cell-therapy-can-control-hiv-infection-reuters/ 2026-07-21T01:28:14+00:00 https://keshavmed.com/news/car-t-therapy-offers-functional-cure-for-hiv-early-study-suggests-%d0%bd%d0%be%d0%b2%d0%be%d1%81%d1%82%d0%b8-gxp-ms/ 2026-07-21T01:28:07+00:00 https://keshavmed.com/news/car-t-therapy-offers-functional-cure-for-hiv-early-study-suggests-%d0%bd%d0%be%d0%b2%d0%be%d1%81%d1%82%d0%b8-gxp-vi/ 2026-07-21T01:28:06+00:00 https://keshavmed.com/news/car-t-therapy-offers-functional-cure-for-hiv-early-study-suggests-%d0%bd%d0%be%d0%b2%d0%be%d1%81%d1%82%d0%b8-gxp-id/ 2026-07-21T01:28:05+00:00 https://keshavmed.com/news/car-t-therapy-offers-functional-cure-for-hiv-early-study-suggests-%d0%bd%d0%be%d0%b2%d0%be%d1%81%d1%82%d0%b8-gxp-th/ 2026-07-21T01:28:05+00:00 https://keshavmed.com/news/car-t-therapy-offers-functional-cure-for-hiv-early-study-suggests-%d0%bd%d0%be%d0%b2%d0%be%d1%81%d1%82%d0%b8-gxp-ar/ 2026-07-21T01:28:04+00:00 https://keshavmed.com/news/car-t-therapy-offers-functional-cure-for-hiv-early-study-suggests-%d0%bd%d0%be%d0%b2%d0%be%d1%81%d1%82%d0%b8-gxp-ru/ 2026-07-21T01:28:04+00:00 https://keshavmed.com/news/car-t-therapy-offers-functional-cure-for-hiv-early-study-suggests-%d0%bd%d0%be%d0%b2%d0%be%d1%81%d1%82%d0%b8-gxp-es/ 2026-07-21T01:28:03+00:00 https://keshavmed.com/news/car-t-therapy-offers-functional-cure-for-hiv-early-study-suggests-%d0%bd%d0%be%d0%b2%d0%be%d1%81%d1%82%d0%b8-gxp-ja/ 2026-07-21T01:28:02+00:00 https://keshavmed.com/news/car-t-therapy-offers-functional-cure-for-hiv-early-study-suggests-%d0%bd%d0%be%d0%b2%d0%be%d1%81%d1%82%d0%b8-gxp-pt/ 2026-07-21T01:28:02+00:00 https://keshavmed.com/news/car-t-therapy-offers-functional-cure-for-hiv-early-study-suggests-%d0%bd%d0%be%d0%b2%d0%be%d1%81%d1%82%d0%b8-gxp-fr/ 2026-07-21T01:28:01+00:00 https://keshavmed.com/news/car-t-therapy-offers-functional-cure-for-hiv-early-study-suggests-%d0%bd%d0%be%d0%b2%d0%be%d1%81%d1%82%d0%b8-gxp-de/ 2026-07-21T01:28:01+00:00 https://keshavmed.com/news/car-t-therapy-offers-functional-cure-for-hiv-early-study-suggests-%d0%bd%d0%be%d0%b2%d0%be%d1%81%d1%82%d0%b8-gxp-zh-tw/ 2026-07-21T01:28:00+00:00 https://keshavmed.com/news/car-t-therapy-offers-functional-cure-for-hiv-early-study-suggests-%d0%bd%d0%be%d0%b2%d0%be%d1%81%d1%82%d0%b8-gxp/ 2026-07-21T01:27:59+00:00 https://keshavmed.com/news/caring-cross-announces-promising-clinical-data-with-single-dose-anti-hiv-car-t-cell-therapy-european-aids-treatment-group-vi/ 2026-07-21T01:27:51+00:00 https://keshavmed.com/news/caring-cross-announces-promising-clinical-data-with-single-dose-anti-hiv-car-t-cell-therapy-european-aids-treatment-group-ms/ 2026-07-21T01:27:51+00:00 https://keshavmed.com/news/caring-cross-announces-promising-clinical-data-with-single-dose-anti-hiv-car-t-cell-therapy-european-aids-treatment-group-th/ 2026-07-21T01:27:50+00:00 https://keshavmed.com/news/caring-cross-announces-promising-clinical-data-with-single-dose-anti-hiv-car-t-cell-therapy-european-aids-treatment-group-ar/ 2026-07-21T01:27:49+00:00 https://keshavmed.com/news/caring-cross-announces-promising-clinical-data-with-single-dose-anti-hiv-car-t-cell-therapy-european-aids-treatment-group-ru/ 2026-07-21T01:27:49+00:00 https://keshavmed.com/news/caring-cross-announces-promising-clinical-data-with-single-dose-anti-hiv-car-t-cell-therapy-european-aids-treatment-group-id/ 2026-07-21T01:27:49+00:00 https://keshavmed.com/news/caring-cross-announces-promising-clinical-data-with-single-dose-anti-hiv-car-t-cell-therapy-european-aids-treatment-group-es/ 2026-07-21T01:27:48+00:00 https://keshavmed.com/news/caring-cross-announces-promising-clinical-data-with-single-dose-anti-hiv-car-t-cell-therapy-european-aids-treatment-group-ja/ 2026-07-21T01:27:47+00:00 https://keshavmed.com/news/caring-cross-announces-promising-clinical-data-with-single-dose-anti-hiv-car-t-cell-therapy-european-aids-treatment-group-pt/ 2026-07-21T01:27:47+00:00 https://keshavmed.com/news/caring-cross-announces-promising-clinical-data-with-single-dose-anti-hiv-car-t-cell-therapy-european-aids-treatment-group-fr/ 2026-07-21T01:27:46+00:00 https://keshavmed.com/news/caring-cross-announces-promising-clinical-data-with-single-dose-anti-hiv-car-t-cell-therapy-european-aids-treatment-group-de/ 2026-07-21T01:27:46+00:00 https://keshavmed.com/news/caring-cross-announces-promising-clinical-data-with-single-dose-anti-hiv-car-t-cell-therapy-european-aids-treatment-group-zh-tw/ 2026-07-21T01:27:45+00:00 https://keshavmed.com/news/caring-cross-announces-promising-clinical-data-with-single-dose-anti-hiv-car-t-cell-therapy-european-aids-treatment-group/ 2026-07-21T01:27:44+00:00 https://keshavmed.com/news/supercharging-immune-cells-may-help-control-hiv-long-term-wired-ms/ 2026-07-21T01:27:36+00:00 https://keshavmed.com/news/supercharging-immune-cells-may-help-control-hiv-long-term-wired-vi/ 2026-07-21T01:27:36+00:00 https://keshavmed.com/news/supercharging-immune-cells-may-help-control-hiv-long-term-wired-id/ 2026-07-21T01:27:35+00:00 https://keshavmed.com/news/supercharging-immune-cells-may-help-control-hiv-long-term-wired-th/ 2026-07-21T01:27:35+00:00 https://keshavmed.com/news/supercharging-immune-cells-may-help-control-hiv-long-term-wired-ar/ 2026-07-21T01:27:34+00:00 https://keshavmed.com/news/supercharging-immune-cells-may-help-control-hiv-long-term-wired-ru/ 2026-07-21T01:27:34+00:00 https://keshavmed.com/news/supercharging-immune-cells-may-help-control-hiv-long-term-wired-pt/ 2026-07-21T01:27:33+00:00 https://keshavmed.com/news/supercharging-immune-cells-may-help-control-hiv-long-term-wired-es/ 2026-07-21T01:27:33+00:00 https://keshavmed.com/news/supercharging-immune-cells-may-help-control-hiv-long-term-wired-de/ 2026-07-21T01:27:32+00:00 https://keshavmed.com/news/supercharging-immune-cells-may-help-control-hiv-long-term-wired-ja/ 2026-07-21T01:27:32+00:00 https://keshavmed.com/news/supercharging-immune-cells-may-help-control-hiv-long-term-wired-zh-tw/ 2026-07-21T01:27:31+00:00 https://keshavmed.com/news/supercharging-immune-cells-may-help-control-hiv-long-term-wired-fr/ 2026-07-21T01:27:31+00:00 https://keshavmed.com/news/supercharging-immune-cells-may-help-control-hiv-long-term-wired/ 2026-07-21T01:27:30+00:00 https://keshavmed.com/news/taimed-completes-phase-2b-enrollment-for-tmb-365-380-hiv-therapy-the-clinical-trial-vanguard-vi/ 2026-07-21T01:27:22+00:00 https://keshavmed.com/news/taimed-completes-phase-2b-enrollment-for-tmb-365-380-hiv-therapy-the-clinical-trial-vanguard-ms/ 2026-07-21T01:27:22+00:00 https://keshavmed.com/news/taimed-completes-phase-2b-enrollment-for-tmb-365-380-hiv-therapy-the-clinical-trial-vanguard-th/ 2026-07-21T01:27:21+00:00 https://keshavmed.com/news/taimed-completes-phase-2b-enrollment-for-tmb-365-380-hiv-therapy-the-clinical-trial-vanguard-id/ 2026-07-21T01:27:20+00:00 https://keshavmed.com/news/taimed-completes-phase-2b-enrollment-for-tmb-365-380-hiv-therapy-the-clinical-trial-vanguard-ru/ 2026-07-21T01:27:20+00:00 https://keshavmed.com/news/taimed-completes-phase-2b-enrollment-for-tmb-365-380-hiv-therapy-the-clinical-trial-vanguard-ar/ 2026-07-21T01:27:19+00:00 https://keshavmed.com/news/taimed-completes-phase-2b-enrollment-for-tmb-365-380-hiv-therapy-the-clinical-trial-vanguard-pt/ 2026-07-21T01:27:18+00:00 https://keshavmed.com/news/taimed-completes-phase-2b-enrollment-for-tmb-365-380-hiv-therapy-the-clinical-trial-vanguard-es/ 2026-07-21T01:27:18+00:00 https://keshavmed.com/news/taimed-completes-phase-2b-enrollment-for-tmb-365-380-hiv-therapy-the-clinical-trial-vanguard-de/ 2026-07-21T01:27:17+00:00 https://keshavmed.com/news/taimed-completes-phase-2b-enrollment-for-tmb-365-380-hiv-therapy-the-clinical-trial-vanguard-ja/ 2026-07-21T01:27:17+00:00 https://keshavmed.com/news/taimed-completes-phase-2b-enrollment-for-tmb-365-380-hiv-therapy-the-clinical-trial-vanguard-fr/ 2026-07-21T01:27:16+00:00 https://keshavmed.com/news/taimed-completes-phase-2b-enrollment-for-tmb-365-380-hiv-therapy-the-clinical-trial-vanguard-zh-tw/ 2026-07-21T01:27:15+00:00 https://keshavmed.com/news/taimed-completes-phase-2b-enrollment-for-tmb-365-380-hiv-therapy-the-clinical-trial-vanguard/ 2026-07-21T01:27:14+00:00 https://keshavmed.com/news/gilead-and-msds-once-weekly-hiv-pill-meets-primary-endpoints-in-phase-iii-trials-clinical-trials-arena-ms/ 2026-07-21T01:27:03+00:00 https://keshavmed.com/news/gilead-and-msds-once-weekly-hiv-pill-meets-primary-endpoints-in-phase-iii-trials-clinical-trials-arena-th/ 2026-07-21T01:27:02+00:00 https://keshavmed.com/news/gilead-and-msds-once-weekly-hiv-pill-meets-primary-endpoints-in-phase-iii-trials-clinical-trials-arena-vi/ 2026-07-21T01:27:02+00:00 https://keshavmed.com/news/gilead-and-msds-once-weekly-hiv-pill-meets-primary-endpoints-in-phase-iii-trials-clinical-trials-arena-ru/ 2026-07-21T01:27:01+00:00 https://keshavmed.com/news/gilead-and-msds-once-weekly-hiv-pill-meets-primary-endpoints-in-phase-iii-trials-clinical-trials-arena-id/ 2026-07-21T01:27:01+00:00 https://keshavmed.com/news/gilead-and-msds-once-weekly-hiv-pill-meets-primary-endpoints-in-phase-iii-trials-clinical-trials-arena-ar/ 2026-07-21T01:27:00+00:00 https://keshavmed.com/news/gilead-and-msds-once-weekly-hiv-pill-meets-primary-endpoints-in-phase-iii-trials-clinical-trials-arena-es/ 2026-07-21T01:26:58+00:00 https://keshavmed.com/news/gilead-and-msds-once-weekly-hiv-pill-meets-primary-endpoints-in-phase-iii-trials-clinical-trials-arena-pt/ 2026-07-21T01:26:56+00:00 https://keshavmed.com/news/gilead-and-msds-once-weekly-hiv-pill-meets-primary-endpoints-in-phase-iii-trials-clinical-trials-arena-ja/ 2026-07-21T01:26:54+00:00 https://keshavmed.com/news/gilead-and-msds-once-weekly-hiv-pill-meets-primary-endpoints-in-phase-iii-trials-clinical-trials-arena-de/ 2026-07-21T01:26:52+00:00 https://keshavmed.com/news/gilead-and-msds-once-weekly-hiv-pill-meets-primary-endpoints-in-phase-iii-trials-clinical-trials-arena-fr/ 2026-07-21T01:26:50+00:00 https://keshavmed.com/news/gilead-and-msds-once-weekly-hiv-pill-meets-primary-endpoints-in-phase-iii-trials-clinical-trials-arena-zh-tw/ 2026-07-21T01:26:48+00:00 https://keshavmed.com/news/gilead-and-msds-once-weekly-hiv-pill-meets-primary-endpoints-in-phase-iii-trials-clinical-trials-arena/ 2026-07-21T01:26:46+00:00 https://keshavmed.com/news/a-quite-fascinating-problem-a-renowned-cu-anschutz-scientist-helps-unlock-hivs-secrets-university-of-colorado-anschutz-ms/ 2026-07-21T01:26:38+00:00 https://keshavmed.com/news/a-quite-fascinating-problem-a-renowned-cu-anschutz-scientist-helps-unlock-hivs-secrets-university-of-colorado-anschutz-vi/ 2026-07-21T01:26:36+00:00 https://keshavmed.com/news/a-quite-fascinating-problem-a-renowned-cu-anschutz-scientist-helps-unlock-hivs-secrets-university-of-colorado-anschutz-th/ 2026-07-21T01:26:34+00:00 https://keshavmed.com/news/a-quite-fascinating-problem-a-renowned-cu-anschutz-scientist-helps-unlock-hivs-secrets-university-of-colorado-anschutz-id/ 2026-07-21T01:26:32+00:00 https://keshavmed.com/news/a-quite-fascinating-problem-a-renowned-cu-anschutz-scientist-helps-unlock-hivs-secrets-university-of-colorado-anschutz-ru/ 2026-07-21T01:26:30+00:00 https://keshavmed.com/news/a-quite-fascinating-problem-a-renowned-cu-anschutz-scientist-helps-unlock-hivs-secrets-university-of-colorado-anschutz-ar/ 2026-07-21T01:26:28+00:00 https://keshavmed.com/news/a-quite-fascinating-problem-a-renowned-cu-anschutz-scientist-helps-unlock-hivs-secrets-university-of-colorado-anschutz-es/ 2026-07-21T01:26:26+00:00 https://keshavmed.com/news/a-quite-fascinating-problem-a-renowned-cu-anschutz-scientist-helps-unlock-hivs-secrets-university-of-colorado-anschutz-pt/ 2026-07-21T01:26:24+00:00 https://keshavmed.com/news/a-quite-fascinating-problem-a-renowned-cu-anschutz-scientist-helps-unlock-hivs-secrets-university-of-colorado-anschutz-ja/ 2026-07-21T01:26:22+00:00 https://keshavmed.com/news/a-quite-fascinating-problem-a-renowned-cu-anschutz-scientist-helps-unlock-hivs-secrets-university-of-colorado-anschutz-de/ 2026-07-21T01:26:20+00:00 https://keshavmed.com/news/a-quite-fascinating-problem-a-renowned-cu-anschutz-scientist-helps-unlock-hivs-secrets-university-of-colorado-anschutz-fr/ 2026-07-21T01:26:18+00:00 https://keshavmed.com/news/a-quite-fascinating-problem-a-renowned-cu-anschutz-scientist-helps-unlock-hivs-secrets-university-of-colorado-anschutz-zh-tw/ 2026-07-21T01:26:15+00:00 https://keshavmed.com/news/a-quite-fascinating-problem-a-renowned-cu-anschutz-scientist-helps-unlock-hivs-secrets-university-of-colorado-anschutz/ 2026-07-21T01:26:13+00:00 https://keshavmed.com/news/uptake-of-long-acting-injectable-hiv-therapy-remains-low-among-medicare-beneficiaries-study-finds-cidrap-ms/ 2026-07-21T01:26:02+00:00 https://keshavmed.com/news/uptake-of-long-acting-injectable-hiv-therapy-remains-low-among-medicare-beneficiaries-study-finds-cidrap-vi/ 2026-07-21T01:26:00+00:00 https://keshavmed.com/news/uptake-of-long-acting-injectable-hiv-therapy-remains-low-among-medicare-beneficiaries-study-finds-cidrap-th/ 2026-07-21T01:25:58+00:00 https://keshavmed.com/news/uptake-of-long-acting-injectable-hiv-therapy-remains-low-among-medicare-beneficiaries-study-finds-cidrap-id/ 2026-07-21T01:25:56+00:00 https://keshavmed.com/news/uptake-of-long-acting-injectable-hiv-therapy-remains-low-among-medicare-beneficiaries-study-finds-cidrap-ru/ 2026-07-21T01:25:54+00:00 https://keshavmed.com/news/uptake-of-long-acting-injectable-hiv-therapy-remains-low-among-medicare-beneficiaries-study-finds-cidrap-ar/ 2026-07-21T01:25:52+00:00 https://keshavmed.com/news/uptake-of-long-acting-injectable-hiv-therapy-remains-low-among-medicare-beneficiaries-study-finds-cidrap-es/ 2026-07-21T01:25:50+00:00 https://keshavmed.com/news/uptake-of-long-acting-injectable-hiv-therapy-remains-low-among-medicare-beneficiaries-study-finds-cidrap-pt/ 2026-07-21T01:25:46+00:00 https://keshavmed.com/news/uptake-of-long-acting-injectable-hiv-therapy-remains-low-among-medicare-beneficiaries-study-finds-cidrap-ja/ 2026-07-21T01:25:44+00:00 https://keshavmed.com/news/uptake-of-long-acting-injectable-hiv-therapy-remains-low-among-medicare-beneficiaries-study-finds-cidrap-de/ 2026-07-21T01:25:42+00:00 https://keshavmed.com/news/uptake-of-long-acting-injectable-hiv-therapy-remains-low-among-medicare-beneficiaries-study-finds-cidrap-fr/ 2026-07-21T01:25:40+00:00 https://keshavmed.com/news/uptake-of-long-acting-injectable-hiv-therapy-remains-low-among-medicare-beneficiaries-study-finds-cidrap-zh-tw/ 2026-07-21T01:25:38+00:00 https://keshavmed.com/news/uptake-of-long-acting-injectable-hiv-therapy-remains-low-among-medicare-beneficiaries-study-finds-cidrap/ 2026-07-21T01:25:36+00:00 https://keshavmed.com/news/dolutegravir-improves-long-term-hiv-outcomes-in-children-and-adolescents-infectious-disease-advisor-ms/ 2026-07-21T01:25:25+00:00 https://keshavmed.com/news/dolutegravir-improves-long-term-hiv-outcomes-in-children-and-adolescents-infectious-disease-advisor-vi/ 2026-07-21T01:25:23+00:00 https://keshavmed.com/news/dolutegravir-improves-long-term-hiv-outcomes-in-children-and-adolescents-infectious-disease-advisor-th/ 2026-07-21T01:25:21+00:00 https://keshavmed.com/news/dolutegravir-improves-long-term-hiv-outcomes-in-children-and-adolescents-infectious-disease-advisor-id/ 2026-07-21T01:25:19+00:00 https://keshavmed.com/news/dolutegravir-improves-long-term-hiv-outcomes-in-children-and-adolescents-infectious-disease-advisor-ru/ 2026-07-21T01:25:17+00:00 https://keshavmed.com/news/dolutegravir-improves-long-term-hiv-outcomes-in-children-and-adolescents-infectious-disease-advisor-ar/ 2026-07-21T01:25:15+00:00 https://keshavmed.com/news/dolutegravir-improves-long-term-hiv-outcomes-in-children-and-adolescents-infectious-disease-advisor-es/ 2026-07-21T01:25:13+00:00 https://keshavmed.com/news/dolutegravir-improves-long-term-hiv-outcomes-in-children-and-adolescents-infectious-disease-advisor-pt/ 2026-07-21T01:25:11+00:00 https://keshavmed.com/news/dolutegravir-improves-long-term-hiv-outcomes-in-children-and-adolescents-infectious-disease-advisor-ja/ 2026-07-21T01:25:09+00:00 https://keshavmed.com/news/dolutegravir-improves-long-term-hiv-outcomes-in-children-and-adolescents-infectious-disease-advisor-de/ 2026-07-21T01:25:06+00:00 https://keshavmed.com/news/dolutegravir-improves-long-term-hiv-outcomes-in-children-and-adolescents-infectious-disease-advisor-fr/ 2026-07-21T01:25:04+00:00 https://keshavmed.com/news/dolutegravir-improves-long-term-hiv-outcomes-in-children-and-adolescents-infectious-disease-advisor-zh-tw/ 2026-07-21T01:25:02+00:00 https://keshavmed.com/news/dolutegravir-improves-long-term-hiv-outcomes-in-children-and-adolescents-infectious-disease-advisor/ 2026-07-21T01:24:59+00:00 https://keshavmed.com/news/hiv-treatment-idvynso-approval-and-clinical-findings-infectious-disease-special-edition-ms/ 2026-07-20T19:15:35+00:00 https://keshavmed.com/news/hiv-treatment-idvynso-approval-and-clinical-findings-infectious-disease-special-edition-vi/ 2026-07-20T19:15:33+00:00 https://keshavmed.com/news/hiv-treatment-idvynso-approval-and-clinical-findings-infectious-disease-special-edition-th/ 2026-07-20T19:15:31+00:00 https://keshavmed.com/news/hiv-treatment-idvynso-approval-and-clinical-findings-infectious-disease-special-edition-id/ 2026-07-20T19:15:29+00:00 https://keshavmed.com/news/hiv-treatment-idvynso-approval-and-clinical-findings-infectious-disease-special-edition-ru/ 2026-07-20T19:15:27+00:00 https://keshavmed.com/news/hiv-treatment-idvynso-approval-and-clinical-findings-infectious-disease-special-edition-ar/ 2026-07-20T19:15:25+00:00 https://keshavmed.com/news/hiv-treatment-idvynso-approval-and-clinical-findings-infectious-disease-special-edition-es/ 2026-07-20T19:15:22+00:00 https://keshavmed.com/news/hiv-treatment-idvynso-approval-and-clinical-findings-infectious-disease-special-edition-pt/ 2026-07-20T19:15:20+00:00 https://keshavmed.com/news/hiv-treatment-idvynso-approval-and-clinical-findings-infectious-disease-special-edition-ja/ 2026-07-20T19:15:18+00:00 https://keshavmed.com/news/hiv-treatment-idvynso-approval-and-clinical-findings-infectious-disease-special-edition-de/ 2026-07-20T19:15:16+00:00 https://keshavmed.com/news/hiv-treatment-idvynso-approval-and-clinical-findings-infectious-disease-special-edition-fr/ 2026-07-20T19:15:14+00:00 https://keshavmed.com/news/hiv-treatment-idvynso-approval-and-clinical-findings-infectious-disease-special-edition-zh-tw/ 2026-07-20T19:15:12+00:00 https://keshavmed.com/news/hiv-treatment-idvynso-approval-and-clinical-findings-infectious-disease-special-edition/ 2026-07-20T19:15:10+00:00 https://keshavmed.com/news/is-an-hiv-cure-possible-the-future-of-hiv-therapy-labiotech-eu-ms/ 2026-07-20T18:22:33+00:00 https://keshavmed.com/news/is-an-hiv-cure-possible-the-future-of-hiv-therapy-labiotech-eu-th/ 2026-07-20T18:22:32+00:00 https://keshavmed.com/news/is-an-hiv-cure-possible-the-future-of-hiv-therapy-labiotech-eu-vi/ 2026-07-20T18:22:32+00:00 https://keshavmed.com/news/is-an-hiv-cure-possible-the-future-of-hiv-therapy-labiotech-eu-ru/ 2026-07-20T18:22:31+00:00 https://keshavmed.com/news/is-an-hiv-cure-possible-the-future-of-hiv-therapy-labiotech-eu-id/ 2026-07-20T18:22:31+00:00 https://keshavmed.com/news/is-an-hiv-cure-possible-the-future-of-hiv-therapy-labiotech-eu-ar/ 2026-07-20T18:22:30+00:00 https://keshavmed.com/news/is-an-hiv-cure-possible-the-future-of-hiv-therapy-labiotech-eu-pt/ 2026-07-20T18:22:29+00:00 https://keshavmed.com/news/is-an-hiv-cure-possible-the-future-of-hiv-therapy-labiotech-eu-es/ 2026-07-20T18:22:29+00:00 https://keshavmed.com/news/is-an-hiv-cure-possible-the-future-of-hiv-therapy-labiotech-eu-ja/ 2026-07-20T18:22:28+00:00 https://keshavmed.com/news/is-an-hiv-cure-possible-the-future-of-hiv-therapy-labiotech-eu-fr/ 2026-07-20T18:22:27+00:00 https://keshavmed.com/news/is-an-hiv-cure-possible-the-future-of-hiv-therapy-labiotech-eu-de/ 2026-07-20T18:22:27+00:00 https://keshavmed.com/news/is-an-hiv-cure-possible-the-future-of-hiv-therapy-labiotech-eu-zh-tw/ 2026-07-20T18:22:26+00:00 https://keshavmed.com/news/is-an-hiv-cure-possible-the-future-of-hiv-therapy-labiotech-eu/ 2026-07-20T18:22:25+00:00 https://keshavmed.com/news/studies-show-that-less-frequent-all-injectable-treatment-for-hiv-is-safe-and-preferred-by-adolescents-st-jude-childrens-research-hospital-ms/ 2026-07-20T18:21:51+00:00 https://keshavmed.com/news/studies-show-that-less-frequent-all-injectable-treatment-for-hiv-is-safe-and-preferred-by-adolescents-st-jude-childrens-research-hospital-vi/ 2026-07-20T18:21:50+00:00 https://keshavmed.com/news/studies-show-that-less-frequent-all-injectable-treatment-for-hiv-is-safe-and-preferred-by-adolescents-st-jude-childrens-research-hospital-id/ 2026-07-20T18:21:49+00:00 https://keshavmed.com/news/studies-show-that-less-frequent-all-injectable-treatment-for-hiv-is-safe-and-preferred-by-adolescents-st-jude-childrens-research-hospital-th/ 2026-07-20T18:21:49+00:00 https://keshavmed.com/news/studies-show-that-less-frequent-all-injectable-treatment-for-hiv-is-safe-and-preferred-by-adolescents-st-jude-childrens-research-hospital-ru/ 2026-07-20T18:21:48+00:00 https://keshavmed.com/news/studies-show-that-less-frequent-all-injectable-treatment-for-hiv-is-safe-and-preferred-by-adolescents-st-jude-childrens-research-hospital-ar/ 2026-07-20T18:21:47+00:00 https://keshavmed.com/news/studies-show-that-less-frequent-all-injectable-treatment-for-hiv-is-safe-and-preferred-by-adolescents-st-jude-childrens-research-hospital-es/ 2026-07-20T18:21:46+00:00 https://keshavmed.com/news/studies-show-that-less-frequent-all-injectable-treatment-for-hiv-is-safe-and-preferred-by-adolescents-st-jude-childrens-research-hospital-ja/ 2026-07-20T18:21:45+00:00 https://keshavmed.com/news/studies-show-that-less-frequent-all-injectable-treatment-for-hiv-is-safe-and-preferred-by-adolescents-st-jude-childrens-research-hospital-pt/ 2026-07-20T18:21:45+00:00 https://keshavmed.com/news/studies-show-that-less-frequent-all-injectable-treatment-for-hiv-is-safe-and-preferred-by-adolescents-st-jude-childrens-research-hospital-fr/ 2026-07-20T18:21:44+00:00 https://keshavmed.com/news/studies-show-that-less-frequent-all-injectable-treatment-for-hiv-is-safe-and-preferred-by-adolescents-st-jude-childrens-research-hospital-de/ 2026-07-20T18:21:44+00:00 https://keshavmed.com/news/studies-show-that-less-frequent-all-injectable-treatment-for-hiv-is-safe-and-preferred-by-adolescents-st-jude-childrens-research-hospital-zh-tw/ 2026-07-20T18:21:43+00:00 https://keshavmed.com/news/studies-show-that-less-frequent-all-injectable-treatment-for-hiv-is-safe-and-preferred-by-adolescents-st-jude-childrens-research-hospital/ 2026-07-20T18:21:37+00:00 https://keshavmed.com/news/%e3%80%90bcj%e3%80%91%e5%a4%8d%e6%97%a6%e8%82%bf%e7%98%a4%e5%8c%bb%e9%99%a2%e6%b3%bd%e5%b8%83%e6%9b%bf%e5%b0%bc%e8%81%94%e5%90%88r-chop%e6%b2%bb%e7%96%97%e6%90%ba%e5%b8%a6%e7%89%b9%e5%ae%9a%e5%9f%ba-v/ 2026-07-20T17:12:54+00:00 https://keshavmed.com/news/%e3%80%90bcj%e3%80%91%e5%a4%8d%e6%97%a6%e8%82%bf%e7%98%a4%e5%8c%bb%e9%99%a2%e6%b3%bd%e5%b8%83%e6%9b%bf%e5%b0%bc%e8%81%94%e5%90%88r-chop%e6%b2%bb%e7%96%97%e6%90%ba%e5%b8%a6%e7%89%b9%e5%ae%9a%e5%9f%ba-m/ 2026-07-20T17:12:54+00:00 https://keshavmed.com/news/%e3%80%90bcj%e3%80%91%e5%a4%8d%e6%97%a6%e8%82%bf%e7%98%a4%e5%8c%bb%e9%99%a2%e6%b3%bd%e5%b8%83%e6%9b%bf%e5%b0%bc%e8%81%94%e5%90%88r-chop%e6%b2%bb%e7%96%97%e6%90%ba%e5%b8%a6%e7%89%b9%e5%ae%9a%e5%9f%ba-t/ 2026-07-20T17:12:53+00:00 https://keshavmed.com/news/%e3%80%90bcj%e3%80%91%e5%a4%8d%e6%97%a6%e8%82%bf%e7%98%a4%e5%8c%bb%e9%99%a2%e6%b3%bd%e5%b8%83%e6%9b%bf%e5%b0%bc%e8%81%94%e5%90%88r-chop%e6%b2%bb%e7%96%97%e6%90%ba%e5%b8%a6%e7%89%b9%e5%ae%9a%e5%9f%ba-r/ 2026-07-20T17:12:52+00:00 https://keshavmed.com/news/%e3%80%90bcj%e3%80%91%e5%a4%8d%e6%97%a6%e8%82%bf%e7%98%a4%e5%8c%bb%e9%99%a2%e6%b3%bd%e5%b8%83%e6%9b%bf%e5%b0%bc%e8%81%94%e5%90%88r-chop%e6%b2%bb%e7%96%97%e6%90%ba%e5%b8%a6%e7%89%b9%e5%ae%9a%e5%9f%ba-i/ 2026-07-20T17:12:52+00:00 https://keshavmed.com/news/%e3%80%90bcj%e3%80%91%e5%a4%8d%e6%97%a6%e8%82%bf%e7%98%a4%e5%8c%bb%e9%99%a2%e6%b3%bd%e5%b8%83%e6%9b%bf%e5%b0%bc%e8%81%94%e5%90%88r-chop%e6%b2%bb%e7%96%97%e6%90%ba%e5%b8%a6%e7%89%b9%e5%ae%9a%e5%9f%ba-a/ 2026-07-20T17:12:51+00:00 https://keshavmed.com/news/%e3%80%90bcj%e3%80%91%e5%a4%8d%e6%97%a6%e8%82%bf%e7%98%a4%e5%8c%bb%e9%99%a2%e6%b3%bd%e5%b8%83%e6%9b%bf%e5%b0%bc%e8%81%94%e5%90%88r-chop%e6%b2%bb%e7%96%97%e6%90%ba%e5%b8%a6%e7%89%b9%e5%ae%9a%e5%9f%ba-e/ 2026-07-20T17:12:50+00:00 https://keshavmed.com/news/%e3%80%90bcj%e3%80%91%e5%a4%8d%e6%97%a6%e8%82%bf%e7%98%a4%e5%8c%bb%e9%99%a2%e6%b3%bd%e5%b8%83%e6%9b%bf%e5%b0%bc%e8%81%94%e5%90%88r-chop%e6%b2%bb%e7%96%97%e6%90%ba%e5%b8%a6%e7%89%b9%e5%ae%9a%e5%9f%ba-j/ 2026-07-20T17:12:49+00:00 https://keshavmed.com/news/%e3%80%90bcj%e3%80%91%e5%a4%8d%e6%97%a6%e8%82%bf%e7%98%a4%e5%8c%bb%e9%99%a2%e6%b3%bd%e5%b8%83%e6%9b%bf%e5%b0%bc%e8%81%94%e5%90%88r-chop%e6%b2%bb%e7%96%97%e6%90%ba%e5%b8%a6%e7%89%b9%e5%ae%9a%e5%9f%ba-p/ 2026-07-20T17:12:49+00:00 https://keshavmed.com/news/%e3%80%90bcj%e3%80%91%e5%a4%8d%e6%97%a6%e8%82%bf%e7%98%a4%e5%8c%bb%e9%99%a2%e6%b3%bd%e5%b8%83%e6%9b%bf%e5%b0%bc%e8%81%94%e5%90%88r-chop%e6%b2%bb%e7%96%97%e6%90%ba%e5%b8%a6%e7%89%b9%e5%ae%9a%e5%9f%ba-d/ 2026-07-20T17:12:48+00:00 https://keshavmed.com/news/%e3%80%90bcj%e3%80%91%e5%a4%8d%e6%97%a6%e8%82%bf%e7%98%a4%e5%8c%bb%e9%99%a2%e6%b3%bd%e5%b8%83%e6%9b%bf%e5%b0%bc%e8%81%94%e5%90%88r-chop%e6%b2%bb%e7%96%97%e6%90%ba%e5%b8%a6%e7%89%b9%e5%ae%9a%e5%9f%ba-f/ 2026-07-20T17:12:47+00:00 https://keshavmed.com/news/%e3%80%90bcj%e3%80%91%e5%a4%8d%e6%97%a6%e8%82%bf%e7%98%a4%e5%8c%bb%e9%99%a2%e6%b3%bd%e5%b8%83%e6%9b%bf%e5%b0%bc%e8%81%94%e5%90%88r-chop%e6%b2%bb%e7%96%97%e6%90%ba%e5%b8%a6%e7%89%b9%e5%ae%9a%e5%9f%ba-z/ 2026-07-20T17:12:45+00:00 https://keshavmed.com/news/%e3%80%90bcj%e3%80%91%e5%a4%8d%e6%97%a6%e8%82%bf%e7%98%a4%e5%8c%bb%e9%99%a2%e6%b3%bd%e5%b8%83%e6%9b%bf%e5%b0%bc%e8%81%94%e5%90%88r-chop%e6%b2%bb%e7%96%97%e6%90%ba%e5%b8%a6%e7%89%b9%e5%ae%9a%e5%9f%ba/ 2026-07-20T17:12:44+00:00 https://keshavmed.com/news/dose-escalation-trial-of-combination-dabrafenib-trametinib-and-at13387-in-patients-with-braf-mutant-solid-tumors-wiley-sons-ms/ 2026-07-20T16:42:06+00:00 https://keshavmed.com/news/dose-escalation-trial-of-combination-dabrafenib-trametinib-and-at13387-in-patients-with-braf-mutant-solid-tumors-wiley-sons-th/ 2026-07-20T16:42:05+00:00 https://keshavmed.com/news/dose-escalation-trial-of-combination-dabrafenib-trametinib-and-at13387-in-patients-with-braf-mutant-solid-tumors-wiley-sons-vi/ 2026-07-20T16:42:05+00:00 https://keshavmed.com/news/dose-escalation-trial-of-combination-dabrafenib-trametinib-and-at13387-in-patients-with-braf-mutant-solid-tumors-wiley-sons-ru/ 2026-07-20T16:42:04+00:00 https://keshavmed.com/news/dose-escalation-trial-of-combination-dabrafenib-trametinib-and-at13387-in-patients-with-braf-mutant-solid-tumors-wiley-sons-id/ 2026-07-20T16:42:04+00:00 https://keshavmed.com/news/dose-escalation-trial-of-combination-dabrafenib-trametinib-and-at13387-in-patients-with-braf-mutant-solid-tumors-wiley-sons-pt/ 2026-07-20T16:42:03+00:00 https://keshavmed.com/news/dose-escalation-trial-of-combination-dabrafenib-trametinib-and-at13387-in-patients-with-braf-mutant-solid-tumors-wiley-sons-es/ 2026-07-20T16:42:03+00:00 https://keshavmed.com/news/dose-escalation-trial-of-combination-dabrafenib-trametinib-and-at13387-in-patients-with-braf-mutant-solid-tumors-wiley-sons-ar/ 2026-07-20T16:42:03+00:00 https://keshavmed.com/news/dose-escalation-trial-of-combination-dabrafenib-trametinib-and-at13387-in-patients-with-braf-mutant-solid-tumors-wiley-sons-de/ 2026-07-20T16:42:02+00:00 https://keshavmed.com/news/dose-escalation-trial-of-combination-dabrafenib-trametinib-and-at13387-in-patients-with-braf-mutant-solid-tumors-wiley-sons-ja/ 2026-07-20T16:42:02+00:00 https://keshavmed.com/news/dose-escalation-trial-of-combination-dabrafenib-trametinib-and-at13387-in-patients-with-braf-mutant-solid-tumors-wiley-sons-zh-tw/ 2026-07-20T16:42:01+00:00 https://keshavmed.com/news/dose-escalation-trial-of-combination-dabrafenib-trametinib-and-at13387-in-patients-with-braf-mutant-solid-tumors-wiley-sons-fr/ 2026-07-20T16:42:01+00:00 https://keshavmed.com/news/dose-escalation-trial-of-combination-dabrafenib-trametinib-and-at13387-in-patients-with-braf-mutant-solid-tumors-wiley-sons/ 2026-07-20T16:41:59+00:00 https://keshavmed.com/news/jco%ef%bc%9a%e6%81%a9%e8%80%83%e8%8a%ac%e5%b0%bc%e5%92%8c%e6%af%94%e7%be%8e%e6%9b%bf%e5%b0%bc%ef%bc%9abraf-v600e%e7%aa%81%e5%8f%98%e9%9d%9e%e5%b0%8f%e7%bb%86%e8%83%9e%e8%82%ba%e7%99%8c%e7%9a%84-ms/ 2026-07-20T15:44:24+00:00 https://keshavmed.com/news/jco%ef%bc%9a%e6%81%a9%e8%80%83%e8%8a%ac%e5%b0%bc%e5%92%8c%e6%af%94%e7%be%8e%e6%9b%bf%e5%b0%bc%ef%bc%9abraf-v600e%e7%aa%81%e5%8f%98%e9%9d%9e%e5%b0%8f%e7%bb%86%e8%83%9e%e8%82%ba%e7%99%8c%e7%9a%84-vi/ 2026-07-20T15:44:23+00:00 https://keshavmed.com/news/jco%ef%bc%9a%e6%81%a9%e8%80%83%e8%8a%ac%e5%b0%bc%e5%92%8c%e6%af%94%e7%be%8e%e6%9b%bf%e5%b0%bc%ef%bc%9abraf-v600e%e7%aa%81%e5%8f%98%e9%9d%9e%e5%b0%8f%e7%bb%86%e8%83%9e%e8%82%ba%e7%99%8c%e7%9a%84-th/ 2026-07-20T15:44:22+00:00 https://keshavmed.com/news/jco%ef%bc%9a%e6%81%a9%e8%80%83%e8%8a%ac%e5%b0%bc%e5%92%8c%e6%af%94%e7%be%8e%e6%9b%bf%e5%b0%bc%ef%bc%9abraf-v600e%e7%aa%81%e5%8f%98%e9%9d%9e%e5%b0%8f%e7%bb%86%e8%83%9e%e8%82%ba%e7%99%8c%e7%9a%84-id/ 2026-07-20T15:44:21+00:00 https://keshavmed.com/news/jco%ef%bc%9a%e6%81%a9%e8%80%83%e8%8a%ac%e5%b0%bc%e5%92%8c%e6%af%94%e7%be%8e%e6%9b%bf%e5%b0%bc%ef%bc%9abraf-v600e%e7%aa%81%e5%8f%98%e9%9d%9e%e5%b0%8f%e7%bb%86%e8%83%9e%e8%82%ba%e7%99%8c%e7%9a%84-ar/ 2026-07-20T15:44:19+00:00 https://keshavmed.com/news/jco%ef%bc%9a%e6%81%a9%e8%80%83%e8%8a%ac%e5%b0%bc%e5%92%8c%e6%af%94%e7%be%8e%e6%9b%bf%e5%b0%bc%ef%bc%9abraf-v600e%e7%aa%81%e5%8f%98%e9%9d%9e%e5%b0%8f%e7%bb%86%e8%83%9e%e8%82%ba%e7%99%8c%e7%9a%84-ru/ 2026-07-20T15:44:19+00:00 https://keshavmed.com/news/jco%ef%bc%9a%e6%81%a9%e8%80%83%e8%8a%ac%e5%b0%bc%e5%92%8c%e6%af%94%e7%be%8e%e6%9b%bf%e5%b0%bc%ef%bc%9abraf-v600e%e7%aa%81%e5%8f%98%e9%9d%9e%e5%b0%8f%e7%bb%86%e8%83%9e%e8%82%ba%e7%99%8c%e7%9a%84-es/ 2026-07-20T15:44:18+00:00 https://keshavmed.com/news/jco%ef%bc%9a%e6%81%a9%e8%80%83%e8%8a%ac%e5%b0%bc%e5%92%8c%e6%af%94%e7%be%8e%e6%9b%bf%e5%b0%bc%ef%bc%9abraf-v600e%e7%aa%81%e5%8f%98%e9%9d%9e%e5%b0%8f%e7%bb%86%e8%83%9e%e8%82%ba%e7%99%8c%e7%9a%84-pt/ 2026-07-20T15:44:17+00:00 https://keshavmed.com/news/jco%ef%bc%9a%e6%81%a9%e8%80%83%e8%8a%ac%e5%b0%bc%e5%92%8c%e6%af%94%e7%be%8e%e6%9b%bf%e5%b0%bc%ef%bc%9abraf-v600e%e7%aa%81%e5%8f%98%e9%9d%9e%e5%b0%8f%e7%bb%86%e8%83%9e%e8%82%ba%e7%99%8c%e7%9a%84-ja/ 2026-07-20T15:44:15+00:00 https://keshavmed.com/news/jco%ef%bc%9a%e6%81%a9%e8%80%83%e8%8a%ac%e5%b0%bc%e5%92%8c%e6%af%94%e7%be%8e%e6%9b%bf%e5%b0%bc%ef%bc%9abraf-v600e%e7%aa%81%e5%8f%98%e9%9d%9e%e5%b0%8f%e7%bb%86%e8%83%9e%e8%82%ba%e7%99%8c%e7%9a%84-de/ 2026-07-20T15:44:14+00:00 https://keshavmed.com/news/jco%ef%bc%9a%e6%81%a9%e8%80%83%e8%8a%ac%e5%b0%bc%e5%92%8c%e6%af%94%e7%be%8e%e6%9b%bf%e5%b0%bc%ef%bc%9abraf-v600e%e7%aa%81%e5%8f%98%e9%9d%9e%e5%b0%8f%e7%bb%86%e8%83%9e%e8%82%ba%e7%99%8c%e7%9a%84-fr/ 2026-07-20T15:44:13+00:00 https://keshavmed.com/news/jco%ef%bc%9a%e6%81%a9%e8%80%83%e8%8a%ac%e5%b0%bc%e5%92%8c%e6%af%94%e7%be%8e%e6%9b%bf%e5%b0%bc%ef%bc%9abraf-v600e%e7%aa%81%e5%8f%98%e9%9d%9e%e5%b0%8f%e7%bb%86%e8%83%9e%e8%82%ba%e7%99%8c%e7%9a%84-en/ 2026-07-20T15:44:12+00:00 https://keshavmed.com/news/jco%ef%bc%9a%e6%81%a9%e8%80%83%e8%8a%ac%e5%b0%bc%e5%92%8c%e6%af%94%e7%be%8e%e6%9b%bf%e5%b0%bc%ef%bc%9abraf-v600e%e7%aa%81%e5%8f%98%e9%9d%9e%e5%b0%8f%e7%bb%86%e8%83%9e%e8%82%ba%e7%99%8c%e7%9a%84-zh-tw/ 2026-07-20T15:44:11+00:00 https://keshavmed.com/news/jco%ef%bc%9a%e6%81%a9%e8%80%83%e8%8a%ac%e5%b0%bc%e5%92%8c%e6%af%94%e7%be%8e%e6%9b%bf%e5%b0%bc%ef%bc%9abraf-v600e%e7%aa%81%e5%8f%98%e9%9d%9e%e5%b0%8f%e7%bb%86%e8%83%9e%e8%82%ba%e7%99%8c%e7%9a%84/ 2026-07-20T15:44:09+00:00